Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics
ReviR Therapeutics, a privately held developer of a suite of small molecule RNA-targeting technologies for […]
TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces the final close of […]
Orbit Discovery and Endevica Bio Enter Multi-target Collaboration to Advance Development of Cachexia Therapeutics
Orbit Discovery, a leader in the discovery of therapeutic peptide hits, today announced it has […]
Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer
Cell BioEngines, a cell and gene therapy company focused on developing an allogenic cell-based product […]
OncoK9 Liquid Biopsy Test Can Enhance Cancer Monitoring in Dogs, New Results Show
PetDx, The Liquid Biopsy Company for Pets™, has released a white paper demonstrating that OncoK9®, […]
EverImmune launches Phase I Clinical Trial for its Oncobiotic Drug Candidate in Lung and Kidney Cancer
EverImmune, a clinical-stage biotechnology company specialized in the development of live biotherapeutic products in the […]
Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million
Immune-Onc Therapeutics, a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints has […]
New Partnership to Boost Research into Vaccines for Cancer
Trials into vaccines for cancer and wider diseases will accelerate after the government reached a […]
A Record Year For People Receiving NHS Cancer Treatment
Thousands more people started vital treatment for cancer over the last year compared to before […]
PVmed Raises US $14 Million Series A Funding
Perception Vision Medical Technologies (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more